Related Experiment Videos
Abnormal FHIT transcripts found in both lung cancer and normal lung tissue
Y Tokuchi1, Y Kobayashi, S Hayashi
1Saitama Cancer Center Research Institute, Ina, Japan.
Genes, Chromosomes & Cancer
|January 14, 1999
Summary
Abnormal FHIT gene transcripts are not specific to lung cancer, appearing in normal tissues too. Their presence may result from splicing errors, not cancer development itself.
Area of Science:
- Molecular biology
- Cancer research
- Genetics
Background:
- Abnormal transcripts of the FHIT (fragile histidine triad) gene are linked to various cancers.
- However, aberrant transcripts also occur in non-neoplastic tissues, making their role in cancer controversial.
Purpose of the Study:
- To investigate FHIT locus alterations in lung cancer.
- To determine if abnormal FHIT transcripts are cancer-specific in lung carcinogenesis.
Main Methods:
- Nested reverse transcription-polymerase chain reaction (RT-PCR) and allelic status analysis.
- Analysis of 88 primary lung cancers, paired normal lung tissues, and normal lung tissues with metastatic cancer.
Main Results:
- Abnormal FHIT transcripts were found in 59% of lung cancers, 35% of paired normal lung, and 64% of control lung tissues.
- No cancer-specific abnormal transcripts were identified, and no correlation was found between FHIT locus heterozygosity and abnormal transcripts.
- Abnormalities likely stem from aberrant splicing and processing.
Conclusions:
- The presence and variety of abnormal FHIT transcripts are not specific to lung cancer.
- FHIT gene abnormalities may arise from splicing issues rather than being a direct cause of lung carcinogenesis.
- Further research on FHIT protein is needed to understand its function in lung cancer.